» Articles » PMID: 35210542

Gut Microbiota and BMI Throughout Childhood: the Role of Firmicutes, Bacteroidetes, and Short-chain Fatty Acid Producers

Overview
Journal Sci Rep
Specialty Science
Date 2022 Feb 25
PMID 35210542
Authors
Affiliations
Soon will be listed here.
Abstract

Childhood obesity is a risk factor for numerous health conditions. A critical factor in the etiology of obesity appears to be the gut microbiota, which is the microbial community that resides in the human gut. The ratio of the phyla Firmicutes and Bacteroidetes (F/B) and gut bacterial genera that produce short-chain fatty acids (SCFA) have been suggested to contribute to obesity. The current study investigated (1) whether differences in F/B ratio can be observed in infancy and childhood in relation to zBMI in healthy children, and (2) whether an innovative proxy measure adds evidence to a relationship between SCFA producers and the etiology of obesity. Stool samples were collected at five time points, and zBMI was assessed at eight time points throughout the first 12 years of life. Our confirmatory analyses with Bayesian multilevel models showed no relationship between the F/B ratio and zBMI. Also, a proxy measure constructed from known SCFA producers was unrelated to zBMI throughout the first 12 years of life. Exploratory analyses using multilevel and random forest models suggest that the relative abundances of Firmicutes and Bacteroidetes were independently negatively associated with zBMI from infancy through childhood, and the SCFA producing genera Subdoligranulum and Alistipes were negatively related to future BMI in childhood.

Citing Articles

Breastfeeding Shapes the Gut Microbiota and Its Structure Is Associated with Weight Gain Trajectories in Mexican Infants.

Arguelles-Lopez A, Aguayo-Patron S, Calderon de la Barca A Nutrients. 2025; 17(5).

PMID: 40077696 PMC: 11901506. DOI: 10.3390/nu17050826.


The Role of the Gut Microbiota in Modulating Signaling Pathways and Oxidative Stress in Glioma Therapies.

Krawczyk A, Sladowska G, Strzalka-Mrozik B Cancers (Basel). 2025; 17(5).

PMID: 40075568 PMC: 11899293. DOI: 10.3390/cancers17050719.


Using gut microbiota and non-targeted metabolomics techniques to study the effect of xylitol on alleviating DSS-induced inflammatory bowel disease in mice.

Ma P, Sun W, Sun C, Tan J, Dong X, He J BMC Immunol. 2025; 26(1):18.

PMID: 40065221 PMC: 11892251. DOI: 10.1186/s12865-025-00700-z.


Impacts of night shift on medical professionals: a pilot study of brain connectivity and gut microbiota.

Yao T, Chao Y, Huang C, Lee H, Liu C, Li K Front Neurosci. 2025; 19:1503176.

PMID: 40035064 PMC: 11872915. DOI: 10.3389/fnins.2025.1503176.


Colonoscopic administration of probiotics to treat irritable bowel syndrome with predominant diarrhea: a randomized placebo-controlled clinical trial.

Wei J, Zhang P, Yang Z, Liu L, Lian T, Isomoto H Surg Endosc. 2025; 39(3):1893-1901.

PMID: 39849073 DOI: 10.1007/s00464-025-11542-6.


References
1.
Saari A, Virta L, Sankilampi U, Dunkel L, Saxen H . Antibiotic exposure in infancy and risk of being overweight in the first 24 months of life. Pediatrics. 2015; 135(4):617-26. DOI: 10.1542/peds.2014-3407. View

2.
Han M, Zhu X, Peng Y, Lin H, Liu D, Li L . The alterations of gut microbiota in mice with chronic pancreatitis. Ann Transl Med. 2019; 7(18):464. PMC: 6803246. DOI: 10.21037/atm.2019.08.18. View

3.
Chakraborti C . New-found link between microbiota and obesity. World J Gastrointest Pathophysiol. 2015; 6(4):110-9. PMC: 4644874. DOI: 10.4291/wjgp.v6.i4.110. View

4.
Schwiertz A, Taras D, Schafer K, Beijer S, Bos N, Donus C . Microbiota and SCFA in lean and overweight healthy subjects. Obesity (Silver Spring). 2009; 18(1):190-5. DOI: 10.1038/oby.2009.167. View

5.
Li Z, Yi C, Katiraei S, Kooijman S, Zhou E, Chung C . Butyrate reduces appetite and activates brown adipose tissue via the gut-brain neural circuit. Gut. 2017; 67(7):1269-1279. DOI: 10.1136/gutjnl-2017-314050. View